The Armed Forces of the Philippines has sought the help of the mayors of Metro Manila to educate their constituents about the relevance of collectively asserting the Philippines’ sovereign rights in the West Philippine Sea…
Mr. Kennedy, Donald Trump’s pick to lead the Department of Health and Human Services, could wield considerable influence over the nation’s food supply. Here’s what we know about his own habits…
The daily effects of strong winds, large waves, as well as rising sea levels — which are fueled by human-caused climate change — are causing beaches on the Outer Banks to wash away…
Key Takeaways In a podcast on Monday, Anthropic CEO Dario Amodei warned that a future with human-level AIs is not far away. In fact, it might happen as soon as… The post Anthropic CEO Says Human-level AI Models Might Arrive By 2026 appeared first on Techreport…
Hundreds of activists formed a human chain outside one of the main plenary halls at the United Nations climate summit on what is traditionally their biggest protest day during the two-week talks. The demonstration in Baku, Azerbaijan will be echoed at sites around the world in a global “day of action” for climate justice that’s…
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Leqembi (lecanemab) to treat mild cognitive impairment and early Alzheimer’s disease, following a re-examination of the clinical data. The recommendation is only for patients who have one or no copies of the apolipoprotein E4 (APOE4) gene…
The European Medicines Agency (EMA) recommended eight medicines for approval this month, including two cancer drugs for treating non-small cell lung cancer (NSCLC). Augtyro for Advanced Cancers The regulatory body’s Committee for Medicinal Products for Human Use (CHMP) supported granting a conditional marketing authorization for Augtyro (repotrectinib…
Following a consultation with its emergency task force, the European Medicines Agency (EMA) has backed a drug for adult patients with acute respiratory distress syndrome (ARDS) induced by the SARS‑CoV-2 virus. As a result, the EMA’s Committee for Medicinal Products for Human Use recommended granting a marketing authorization “under exceptional circumstances” for Gohibic (vilobelimab…